Dr. Anna Lacasta received her PhD in Environmental Microbiology and Biotechnology in 2013 from the Universitat de Barcelona (UB). Her PhD work was based on the identification of new antigens against ASFV and the identification of the immune mechanisms involved in natural protection. During her training work, Anna gained extensive expertise in the design of in vivo experiments (BSL3+ conditions at IRTA-CReSA) involving large animals and in the immunological and molecular biology assays as well. Using her expertise in the field of vaccinology Anna held a post-doctoral position at ILRI from 2013 working in a subunit vaccine against the sporozoite phase of T.parva parasite, the causative agent of ECF. From this work 13 peer-reviewed papers were generated. Currently Anna in involved in a BMGF-funded and IDRC-funded ECF projects and an IDRC-funded and IVVN ASFV project to generate attenuated recombinant ASFV viruses and subunit vaccines.